ly3298176 tirzepatide hydrochloride (LY3298176 hydrochloride) | AbMole BioScience JCI Insight - Tirzepatide is
Description
1998;155:1626b1626
Diabetes 010;33(6):03
(C) Cells were treated as (B), then stained with primary antibodies of BCL2 and Bax followed by staining with secondary antibodies
It started around week [number] and has been [getting better / staying the same / getting worse]
8 , 339ra369 (2016)
Proc Natl Acad Sci U S A 2020;117:4910-20
32260-8/asset/b3e92579-8c29-4267-895b-56d26c1d4c0b/main.assets/gr3_lrg.jpg)
